Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014–2018)
Université Paris-Est Créteil · Assistance Publique – Hôpitaux de Paris · +52 more institutions
Abstract
A group of European experts reappraised the guidelines on the therapeutic efficacy of repetitive transcranial magnetic stimulation (rTMS) previously published in 2014 [Lefaucheur et al., Clin Neurophysiol 2014;125:2150-206]. These updated recommendations take into account all rTMS publications, including data prior to 2014, as well as currently reviewed literature until the end of 2018. Level A evidence (definite efficacy) was reached for: high-frequency (HF) rTMS of the primary motor cortex (M1) contralateral to the painful side for neuropathic pain; HF-rTMS of the left dorsolateral prefrontal cortex (DLPFC) using a figure-of-8 or a H1-coil for depression; low-frequency (LF) rTMS of contralesional M1 for hand…
Citation impact
- FWCI
- 100.88
- Percentile
- 100%
- References
- 604
Authors
31- JLJean‐Pascal LefaucheurCorresponding
Université Paris-Est Créteil, Assistance Publique – Hôpitaux de Paris, Hôpitaux Universitaires Henri-Mondor
- AAAndré Alemán
University Medical Center Groningen, University of Groningen
- CBChris Baeken
Ghent University Hospital, Eindhoven University of Technology
- DBDavid Benninger
University Hospital of Lausanne
- JBJérôme Brunelin
Université Claude Bernard Lyon 1, Centre National de la Recherche Scientifique, Inserm, Centre de Recherche en Neurosciences de Lyon, Centre Hospitalier Le Vinatier
Topics & keywords
- Transcranial magnetic stimulation
- Dorsolateral prefrontal cortex
- Deep transcranial magnetic stimulation
- Stroke (engine)
- Physical medicine and rehabilitation
- Psychology
- Primary motor cortex
- Motor cortex
Funding
- PPfizer
- BBiogen
- BBrainsWay
- FEFederación Española de Enfermedades Raras
- MPMinistarstvo Prosvete, Nauke i Tehnološkog RazvojaAward: OI175012
- MDMinistério da Ciência, Tecnologia e Ensino Superior
- SServier
- HLH. Lundbeck A/S
- SSchuhfried
- CCorTec
- FPFundação para a Ciência e a TecnologiaAwards: 01-0145, /2017, LISBOA-01-0145-FEDER
- JPJanssen Pharmaceuticals
- CCilag